| Net (Loss) Income Per Share |
14.Net (loss) income per share The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
Basic (loss) income per share: |
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
Net (loss) income |
|
$ |
(131,120 |
) |
|
$ |
52,231 |
|
Deemed dividend for anti-dilution adjustments to Series B and Series C redeemable convertible preferred stock upon issuance of Series D Preferred Stock |
|
|
— |
|
|
|
(14,972 |
) |
Allocation of undistributed earnings to participating securities |
|
|
— |
|
|
|
(33,854 |
) |
Net (loss) income attributable to common stockholders, basic |
|
$ |
(131,120 |
) |
|
$ |
3,405 |
|
Denominator: |
|
|
|
|
|
|
Weighted-average shares of common stock outstanding |
|
|
42,986,396 |
|
|
|
2,421,566 |
|
Less: weighted-average shares of common stock subject to repurchase |
|
|
(10,372 |
) |
|
|
(25,472 |
) |
Weighted-average shares of common stock outstanding used in the calculation of (loss) income per share attributable to common stockholders, basic |
|
|
42,976,024 |
|
|
|
2,396,094 |
|
Net (loss) income per share attributable to common stockholders, basic |
|
$ |
(3.05 |
) |
|
$ |
1.42 |
|
Diluted (loss) income per share: |
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
Net (loss) income attributable to common stockholders, basic and diluted |
|
$ |
(131,120 |
) |
|
$ |
3,405 |
|
Denominator: |
|
|
|
|
|
|
Weighted-average shares of common stock outstanding, basic |
|
|
42,976,024 |
|
|
|
2,396,094 |
|
Weighted-average dilutive effect of equity awards |
|
|
— |
|
|
|
334,205 |
|
Weighted-average shares of common stock outstanding, diluted |
|
|
42,976,024 |
|
|
|
2,730,299 |
|
Net (loss) income per share attributable to common stockholders, diluted |
|
$ |
(3.05 |
) |
|
$ |
1.25 |
|
The potential shares of common stock that were excluded from the computation of diluted net (loss) income per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
Shares subject to outstanding stock options |
|
|
5,484,226 |
|
|
|
1,521,486 |
|
Shares subject to outstanding restricted stock units |
|
|
593,525 |
|
|
|
— |
|
Unvested restricted stock subject to repurchase |
|
|
10,372 |
|
|
|
10,372 |
|
Total |
|
|
6,088,123 |
|
|
|
1,531,858 |
|
The potential shares of common stock associated with the Convertible Promissory Notes that converted to Series D-1 Preferred Stock would have been antidilutive, but are not included in the table above as the Convertible Promissory Notes were no longer outstanding as of December 31, 2024.
|